These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29135251)

  • 1. Micellar Thrombin-Binding Aptamers: Reversible Nanoscale Anticoagulants.
    Roloff A; Carlini AS; Callmann CE; Gianneschi NC
    J Am Chem Soc; 2017 Nov; 139(46):16442-16445. PubMed ID: 29135251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.
    Rangnekar A; Zhang AM; Li SS; Bompiani KM; Hansen MN; Gothelf KV; Sullenger BA; LaBean TH
    Nanomedicine; 2012 Jul; 8(5):673-81. PubMed ID: 21889476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin inhibitors based on single-stranded DNA aptamers.
    Gribkova IV; Spiridonova VA; Gorbatenko AS; Denisov SS; Ataullakhanov FI; Sinauridze EI
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):39-45. PubMed ID: 24247320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant.
    Huang SS; Wei SC; Chang HT; Lin HJ; Huang CC
    J Control Release; 2016 Jan; 221():9-17. PubMed ID: 26643617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer Conjugated RNA/DNA Hybrid Nanostructures Designed for Efficient Regulation of Blood Coagulation.
    Rolband LA; Ke W; Afonin KA
    Methods Mol Biol; 2023; 2709():277-286. PubMed ID: 37572288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Complexation of Aptamers by Their Specific Antidotes.
    Stoll H; Steinle H; Wilhelm N; Hann L; Kunnakattu SJ; Narita M; Schlensak C; Wendel HP; Avci-Adali M
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28594360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new anticoagulant-antidote pair: control of thrombin activity by aptamers and porphyrins.
    Joachimi A; Mayer G; Hartig JS
    J Am Chem Soc; 2007 Mar; 129(11):3036-7. PubMed ID: 17319665
    [No Abstract]   [Full Text] [Related]  

  • 8. Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures.
    Rangnekar A; Nash JA; Goodfred B; Yingling YG; LaBean TH
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26861277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
    Hughes QW; Le BT; Gilmore G; Baker RI; Veedu RN
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29048375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient control of thrombin activity by multivalent nanoparticles.
    Hsu CL; Chang HT; Chen CT; Wei SC; Shiang YC; Huang CC
    Chemistry; 2011 Sep; 17(39):10994-1000. PubMed ID: 21850727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-Nanoscaffold-Assisted Selection of Femtomolar Bivalent Human α-Thrombin Aptamers with Potent Anticoagulant Activity.
    Zhou Y; Qi X; Liu Y; Zhang F; Yan H
    Chembiochem; 2019 Oct; 20(19):2494-2503. PubMed ID: 31083763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.
    Zavyalova E; Samoylenkova N; Revishchin A; Golovin A; Pavlova G; Kopylov A
    PLoS One; 2014; 9(9):e107113. PubMed ID: 25192011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel modular DNA aptamer for human thrombin with high anticoagulant activity.
    Zavyalova E; Golovin A; Reshetnikov R; Mudrik N; Panteleyev D; Pavlova G; Kopylov A
    Curr Med Chem; 2011; 18(22):3343-50. PubMed ID: 21728967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
    Bompiani KM; Monroe DM; Church FC; Sullenger BA
    J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA aptamers for human thrombin with high anticoagulant activity demonstrate target- and species-specificity.
    Zavyalova E; Golovin A; Timoshenko T; Babiy A; Pavlova G; Kopylov A
    Curr Med Chem; 2012; 19(30):5232-7. PubMed ID: 22934762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cation Coordination Alters the Conformation of a Thrombin-Binding G-Quadruplex DNA Aptamer That Affects Inhibition of Thrombin.
    Zavyalova E; Tagiltsev G; Reshetnikov R; Arutyunyan A; Kopylov A
    Nucleic Acid Ther; 2016 Oct; 26(5):299-308. PubMed ID: 27159247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent Aptamer-Functionalized Single-Strand RNA Origami as Effective, Target-Specific Anticoagulants with Corresponding Reversal Agents.
    Krissanaprasit A; Key CM; Froehlich K; Pontula S; Mihalko E; Dupont DM; Andersen ES; Kjems J; Brown AC; LaBean TH
    Adv Healthc Mater; 2021 Jun; 10(11):e2001826. PubMed ID: 33882195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Backbone modified TBA analogues endowed with antiproliferative activity.
    Esposito V; Russo A; Amato T; Varra M; Vellecco V; Bucci M; Russo G; Virgilio A; Galeone A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1213-1221. PubMed ID: 27663232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer.
    Musumeci D; Montesarchio D
    Pharmacol Ther; 2012 Nov; 136(2):202-15. PubMed ID: 22850531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent anti-coagulant RNA aptamer inhibits blood coagulation by specifically blocking the extrinsic clotting pathway.
    Gopinath SC; Shikamoto Y; Mizuno H; Kumar PK
    Thromb Haemost; 2006 May; 95(5):767-71. PubMed ID: 16676065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.